SLC35F5 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 7.66053886991358E-15 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.1334045641197E-12 |
Normal-vs-Stage2 |
4.23989998665775E-09 |
Normal-vs-Stage3 |
1.62447832963153E-12 |
Normal-vs-Stage4 |
1.62525548574877E-12 |
Stage1-vs-Stage2 |
8.612000E-01 |
Stage1-vs-Stage3 |
2.384500E-04 |
Stage1-vs-Stage4 |
7.856800E-03 |
Stage2-vs-Stage3 |
2.112200E-02 |
Stage2-vs-Stage4 |
6.568000E-02 |
Stage3-vs-Stage4 |
7.200600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
3.33066907387547E-15 |
Normal-vs-AfricanAmerican |
6.3342000533595E-09 |
Normal-vs-Asian |
2.842100E-02 |
Caucasian-vs-AfricanAmerican |
1.829820E-01 |
Caucasian-vs-Asian |
1.804620E-01 |
AfricanAmerican-vs-Asian |
5.267800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
4.44089209850063E-16 |
Normal-vs-Female |
6.15063555642337E-12 |
Male-vs-Female |
3.042000E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.27230004309808E-10 |
Normal-vs-Age(41-60Yrs) |
7.07212066686225E-14 |
Normal-vs-Age(61-80Yrs) |
1.6295853555448E-12 |
Normal-vs-Age(81-100Yrs) |
1.90600000005148E-07 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.166400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.301600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.514800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.835000E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.096600E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.254600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.962430E-03 |
Normal-vs-Grade 2 |
3.62354590777159E-12 |
Normal-vs-Grade 3 |
1.62736490949555E-12 |
Normal-vs-Grade 4 |
1.62458935193399E-12 |
Grade 1-vs-Grade 2 |
6.010200E-01 |
Grade 1-vs-Grade 3 |
1.434370E-01 |
Grade 1-vs-Grade 4 |
3.216600E-03 |
Grade 2-vs-Grade 3 |
2.612200E-02 |
Grade 2-vs-Grade 4 |
5.53170000028302E-07 |
Grade 3-vs-Grade 4 |
1.499360E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
9.86777326517085E-12 |
Normal-vs-ccB subtype |
3.33066907387547E-16 |
ccA subtype-vs-ccB subtype |
2.791500E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
4.72955008490317E-14 |
Normal-vs-N1 |
1.50860000003306E-06 |
N0-vs-N1 |
3.068200E-01 |
|
|